Initial studies on the diabetes drug, rosiglitazone, show that the medication may improve memory and cognitive performance of patients with Alzheimer's Disease. Initial lab test on rosiglitazone appears to restore the brain signals needed for proper brain cognition.
Alzheimer's Disease is a condition that affects the patient's brain functions such as memory, thinking, cognition, and psychological behavior. It is a type of dementia that slowly progresses throughout the whole of the brain destroying healthy brain cells.
Alzheimer's disease has no known cure and is caused by protein fragments in the brain called plaques. These plaques form into the alzheimer protein that is responsible for the destruction of healthy brain cells.
Alzheimer's Disease is a condition that affects the patient's brain functions such as memory, thinking, cognition, and psychological behavior. It is a type of dementia that slowly progresses throughout the whole of the brain destroying healthy brain cells.
Alzheimer's disease has no known cure and is caused by protein fragments in the brain called plaques. These plaques form into the alzheimer protein that is responsible for the destruction of healthy brain cells.

